Eiger BioPharmaceuticals, Inc. (EIGRQ)
USD 8.5
(6.25%)
USD 8.5
(6.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 15.77 Million | 13.48 Million | 12.14 Million | - | - | - |
| Cost of Revenue | 774 Thousand | 2.67 Million | 1.54 Million | 645 Thousand | 486 Thousand | 54 Thousand |
| Gross Profit | 14.99 Million | 10.8 Million | 10.59 Million | -645 Thousand | -486 Thousand | -54 Thousand |
| Operating Expenses | 86.78 Million | 103.54 Million | 87.53 Million | 61.5 Million | 68.41 Million | 50.99 Million |
| Selling, General and Administrative Expenses | 24.45 Million | 28.26 Million | 23.1 Million | 19.91 Million | 16.62 Million | 13.9 Million |
| Research and Development Expenses | 62.33 Million | 75.28 Million | 64.43 Million | 41.59 Million | 51.79 Million | 37.09 Million |
| Other Expenses | 87 Thousand | -963 Thousand | 46.48 Million | -12 Thousand | - | - |
| Cost and Expenses | 87.55 Million | 106.22 Million | 89.08 Million | 62.14 Million | 68.9 Million | 51.04 Million |
| Operating Income | -71.78 Million | -92.74 Million | -76.93 Million | -62.14 Million | -68.9 Million | -51.04 Million |
| Interest Expense | 5.46 Million | 4.13 Million | 3.55 Million | 3.59 Million | - | 2.32 Million |
| Income Tax Expense | 6000.00 | 23 Thousand | 64 Thousand | - | - | - |
| Earnings before Tax | -74.95 Million | -96.75 Million | -33.85 Million | -65.05 Million | -70.25 Million | -52.39 Million |
| Net Income | -74.96 Million | -96.77 Million | -33.91 Million | -65.05 Million | -70.25 Million | -52.39 Million |
| Earnings Per Share Basic | -50.78 | -69.74 | -29.98 | -69.34 | -92.50 | -114.63 |
| Earnings Per Share Diluted | -50.78 | -69.74 | -29.98 | -69.34 | -92.50 | -114.63 |
| Weighted Average Shares Outstanding | 1.47 Million | 1.38 Million | 1.13 Million | 938.11 Thousand | 759.52 Thousand | 457.03 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.47 Million | 1.38 Million | 1.13 Million | 938.11 Thousand | 759.52 Thousand | 457.03 Thousand |
| Gross Margin | 0.95 | 0.80 | 0.87 | - | - | - |
| EBIT Margin | -4.50 | -6.82 | -6.27 | - | - | - |
| Profit Margin | -4.75 | -7.18 | -2.79 | - | - | - |
| EBITDA | -71.03 Million | -91.89 Million | -76.14 Million | -61.5 Million | -68.41 Million | -50.99 Million |
| Earnings Before Tax Margin | -4.55 | -6.88 | -6.34 | - | - | - |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 15.77 Million | 3.8 Million | 3.2 Million | 4.64 Million | 4.11 Million | 13.48 Million |
| Cost of Revenue | 774 Thousand | 281 Thousand | 313 Thousand | -127 Thousand | 307 Thousand | 2.67 Million |
| Gross Profit | 14.99 Million | 3.52 Million | 2.89 Million | 4.77 Million | 3.81 Million | 10.8 Million |
| Operating Expenses | 86.78 Million | 16.13 Million | 19.82 Million | 24.75 Million | 26.07 Million | 103.54 Million |
| Selling, General and Administrative Expenses | - | 4.52 Million | 5.25 Million | 5.35 Million | 9.32 Million | - |
| Research and Development Expenses | - | 11.61 Million | 14.56 Million | 19.4 Million | 16.74 Million | - |
| Other Expenses | 87 Thousand | 236 Thousand | -175 Thousand | -29 Thousand | 55 Thousand | -963 Thousand |
| Cost and Expenses | 87.55 Million | 16.41 Million | 20.13 Million | 24.62 Million | 26.38 Million | 106.22 Million |
| Operating Income | -71.78 Million | -12.61 Million | -16.92 Million | -19.98 Million | -22.26 Million | -92.74 Million |
| Interest Expense | 5.46 Million | 1.42 Million | 1.41 Million | 1.34 Million | 1.28 Million | 4.13 Million |
| Income Tax Expense | 6000.00 | 2000.00 | - | 2000.00 | 2000.00 | 23 Thousand |
| Earnings before Tax | -74.95 Million | -13.45 Million | -18.03 Million | -20.69 Million | -22.78 Million | -96.75 Million |
| Net Income | -74.96 Million | -13.45 Million | -18.03 Million | -20.69 Million | -22.78 Million | -96.77 Million |
| Earnings Per Share Basic | - | -9.09 | -12.20 | -14.02 | -15.48 | - |
| Earnings Per Share Diluted | - | -9.09 | -12.20 | -14.02 | -15.48 | - |
| Weighted Average Shares Outstanding | 1.47 Million | 1.47 Million | 1.47 Million | 1.47 Million | 1.47 Million | 1.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.47 Million | 1.47 Million | 1.47 Million | 1.47 Million | 1.47 Million | 1.38 Million |
| Gross Margin | 0.95 | 0.93 | 0.90 | 1.03 | 0.93 | 0.80 |
| EBIT Margin | - | -3.27 | -5.21 | -4.26 | -5.36 | - |
| Profit Margin | -4.75 | -3.54 | -5.62 | -4.46 | -5.53 | -7.18 |
| EBITDA | - | -12.43 Million | -16.73 Million | -19.79 Million | -22.07 Million | - |
| Earnings Before Tax Margin | -4.55 | -3.32 | -5.28 | -4.30 | -5.41 | -6.88 |
SIS
BAESF
NSARO
600375
0ITS
PEBO